The transcription factor PPAR (Peroxisome Proliferator-activated Receptor) alpha is overexpressed and is associated with a favourable prognosis in IDH-wildtype primary glioblastoma (2018)
Attributed to:
Malignant Glioma immunotherapy by histone deacetylase inhibition administered by convection enhanced delivery.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/neuonc/nox238.091
Publication URI: http://dx.doi.org/10.1093/neuonc/nox238.091
Type: Journal Article/Review
Parent Publication: Neuro-Oncology
Issue: suppl_1